Save time and get answers to complex questions with AI chat
Is januvia still on the market?Is it okay to take anti histamine when on statins?What are the most memorable drug brands in oral factor b inhibitors? in united statesAlogliptin benz cost?Can wine consumption affect lipitor's cholesterol lowering ability?
See the DrugPatentWatch profile for Humira
Do you mean launch dates by region (US vs EU vs other markets) or for specific biosimilars? A region-by-region timeline is a bit different because approvals and launches happened at different times. Brief overview (to set expectations): - United States: After Humira’s exclusivity ended, several adalimumab biosimilars began launching in 2023, with additional entrants in 2024. - European Union: Adalimumab biosimilars entered the market earlier, starting around 2018–2019, and continued to broaden availability through the early 2020s. - Other markets: Launch dates vary widely by country and payer/regulatory decisions, from 2019 onward in many regions. If you tell me the region and (optionally) the specific biosimilars you care about, I can give you a precise, sourced timeline.
Other Questions About Humira :